Veeva Systems ($VEEV) is helping companies across the healthcare and pharma space fight the Coronavirus outbreak, and it's one of the exceedingly rare stocks in the market to see shares rise in 2020. 

Veeva Engage is one of the company's tools utilized by healthcare sector companies to allow remote meetings with patients. CEO Peter Glassner told CNBC last week that his product is seeing a "tenfold" increase in engagement as telework and telehealth have been key in the continuing fight against Coronavirus. Veeva is making Engage free to new clients to help promote remote meetings with healthcare professionals and to reduce the spread of the virus. 

All this engagement is helping to drive hiring with Veeva Systems, it looks like. 

At a time when many other companies are slashing job openings to brace against the immediate decline in revenue, Veeva job postings shot up more than 22% over the course of 2020, as depicted by our chart above. 

For Veeva, its popularity has not been nearly as intense as Zoom's. While Zoom has earned growing attention - not all of it good, mind you - Veeva's Twitter ($TWTR) Follower growth has been comparatively muted, rising just 3.5% in 2020. Veeva Engage is powered by Zoom - and Veeva CEO Peter Glassner sits on the boards of both companies. 

Much like Zoom, Veeva's rare stock performance may be worth following as it and other players in the telehealth space - like Teladoc - continue to see rising engagement from consumers looking to flatten the curve with social distancing. 

About the Data:

Thinknum tracks companies using the information they post online - jobs, social and web traffic, product sales and app ratings - and creates data sets that measure factors like hiring, revenue and foot traffic. Data sets may not be fully comprehensive (they only account for what is available on the web), but they can be used to gauge performance factors like staffing and sales. 

Further Reading: 

Ad placeholder